Efficacy, tolerability, compliance, and quality of life of patients with mood disorders switched from Quetiapine immediate release to extended release

International Clinical Psychopharmacology

Volumn 27, Issue 6, 2012, Pages 310-313

  Dell'Osso, Bernardo ^a   Arici, Chiara ^a   Dobrea, Cristina ^a   Benatti, Beatrice ^a   Carlo Altamura, A ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

bipolar disorder; compliance; efficacy; extended release immediate release; major depressive disorder; quality of life; Quetiapine; tolerability

Indexed keywords

BENZODIAZEPINE; QUETIAPINE;

ADULT; APPETITE; ARTICLE; ASTHENIA; BIPOLAR DISORDER; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CONSTIPATION; DAYTIME SOMNOLENCE; DRUG EFFICACY; DRUG RELEASE; DRUG TOLERABILITY; FEMALE; HAMILTON ANXIETY SCALE; HAMILTON SCALE; HUMAN; INSOMNIA; MAJOR DEPRESSION; MALE; MOOD DISORDER; NATURALISTIC INQUIRY; OPEN STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOMETRY; QUALITY OF LIFE; SIDE EFFECT; WEIGHT;

ADULT; CHEMISTRY, PHARMACEUTICAL; CROSS-OVER STUDIES; DELAYED-ACTION PREPARATIONS; DIBENZOTHIAZEPINES; DRUG SUBSTITUTION; FEMALE; HUMANS; MALE; MIDDLE AGED; MOOD DISORDERS; PATIENT COMPLIANCE; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 84866990644     PISSN: 02681315     EISSN: 14735857     Source Type: Journal    
DOI: 10.1097/YIC.0b013e328358f0c6     Document Type: Article

References (21)

1. American Psychiatric Association (2000). Diagnostic and statistical manual of mental disorders. 4th ed. Text Revision Washington DC: American Psychiatric Association.
2. Bauer M, Pretorius HW, Constant EL, Earley WR, Szamosi J, Brecher M (2009). Extended-release quetiapine as adjunct to an antidepressant in patients with major depressive disorder: results of a randomized, placebo-controlled, double-blind study. J Clin Psychiatry 70:540-549.
3. Byerly MJ, Nakonezny PA, Rush AJ (2008). The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder. Schizophr Res 100:60-69.
4. Datto C, Berggren L, Patel JB, Eriksson H (2009). Self-reported sedation profile of immediate-release quetiapine fumarate compared with extended-release quetiapine fumarate during dose initiation: a randomized, double-blind, crossover study in healthy adult subjects. Clin Ther 31:492-502.
5. El-Khalili N, Joyce M, Atkinson S, Buynak RJ, Datto C, Lindgren P, Eriksson H (2010). Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study. Int J Neuropsychopharmacol 23:1-16.
6. Figueroa C, Brecher M, Hamer-Maansson JE,Winter H (2009). Pharmacokinetic profiles of estende release quetiapine fumarate compared with quetiapine immediate release. Prog Neuropsychopharmacol Biol Psychiatry 33: 199-204.
7. First MB, Gibbon M, Spitzer RL,Williams JBW, Benjamin LS (1997). Structured clinical interview for DSM-IV axis II Personality Disorders (SCID-II). Washington DC: American Psychiatric Press.
8. First MB, Spitzer R, Gibbon M, Williams JBW (2002). Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. (SCID-I/P). New York: Biometrics Research, New York State Psychiatric Institute.
9. Guy W (1976). Clinical Global Impressions: In ECDEU Assessment Manual for Psychopharmacology. Revised DHEW Pub. (ADM). Rockville, MD: National Institute for Mental Health; pp. 218-222.
10. Hamilton M (1959). The assessment of anxiety states by rating. Br J Med Psychol 32:50-55.
11. Hamilton M (1960). A Rating Scale for Depression. J Neurol Neurosurg Psychiat 23:56-62.
12. Judd LL, Akiskal HS, Maser JD, Zeller PJ, Endicott J, Coryell W, et al. (1998). Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse. J Affect Disord 50:97-108. (Pubitemid 28551779)
13. Mamo DC, Uchida H, Vitcu I, Barsoum P, Gendron A, Goldstein J, Kapur S (2008). Quetiapine extended-release versus immediate-release formulation: a positron emission tomography study. J Clin Psychiatry 69:81-86. (Pubitemid 351282000)
14. McIntyre RS, Muzina DJ, Adams A, Lourenco MT, Law CW, Soczynska JK, et al. (2009). Quetiapine XR efficacy and tolerability as monotherapy and as adjunctive treatment to conventional antidepressants in the acute and maintenance treatment of major depressive disorder: a review of registration trials. Expert Opin Pharmacother 10:3061-3075.
15. Montgomery SA, Asberg M (1979). A new depression scale designed to be sensitive to change. Young Mania Rating Scale (YMRS). Br J Psychiatry 134:382-389. (Pubitemid 9136500)
16. Pae CU, Sohi MS, Seo HJ, Patkar AA, Steffens DC, Masand PS (2010). Quetiapine XR: Current status for the treatment of major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 34:1165-1173.
17. Riesenberg RA, Datto C, Baldytcheve I (2011). Sedation intensity during dose escalation of quetiapine XR or IR in bipolar depression: a multicenter, doubleblind, randomized, phase IV study. Presented at the 11th International Forum on Mood and Anxiety Disorders, 9-11 November 2011, Budapest, Hungary.
18. Sheehan DV, Harnet Sheehan K, Raj BA (1996). The measurement of disability. Int Clin Psychopharm 11 (s3):89-95. (Pubitemid 26373761)
19. Suppes T, Datto C, Minkwitz M, Nordenhem A, Walker C, Darko D (2010). Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression. J Affect Disord 121:106-115.
20. Weisler R, Joyce M, McGill L, Lazarus A, Szamosi J, Eriksson H. Moonstone Study Group (2009). Extended release quetiapine fumarate monotherapy for major depressive disorder: results of a double-blind, randomized, placebocontrolled study. CNS Spectr 14:299-313.
21. Young RC, Biggs JT, Ziegler VE, Meyer DA (1978). A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 133:429-435. (Pubitemid 9006756)